Latest Commercialization News

Page 71 of 454
AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.
Ada Torres
Ada Torres
21 Jan 2026
Vulcan Energy has reported strong production test results from its LSC-1b sidetrack well, reinforcing the viability of its Phase One Lionheart lithium project in Germany. The well’s performance supports the project’s ambitious lithium and renewable energy production targets.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.
Ada Torres
Ada Torres
21 Jan 2026
Audeara Ltd reported a strong Q2 FY26 with revenues up 274% year-on-year, securing key regulatory approval in China and expanding its global licensing footprint.
Ada Torres
Ada Torres
21 Jan 2026
VHM Limited has made significant strides in developing its Goschen Rare Earths and Mineral Sands Project, securing substantial funding and critical regulatory approvals while expanding its resource base.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Firebrick Pharma has introduced its Nasodine Throat Spray in Singapore, marking its first international product launch and setting the stage for further global rollouts in 2026.
Ada Torres
Ada Torres
21 Jan 2026
Everest Metals Corporation, in partnership with Edith Cowan University, has won a $490,500 grant to accelerate its innovative rubidium extraction technology at the Mt Edon project, positioning Australia to establish its first sovereign rubidium supply.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Pointerra Limited reported a 30% increase in customer receipts to A$2.6 million and positive operating cashflows in Q2 FY26, driven by major contracts including a US$2 million DOE grant with Georgia Power. The company’s digital twin SaaS platform continues to expand across key sectors, positioning it for sustained growth.
Sophie Babbage
Sophie Babbage
21 Jan 2026
Mayfield Childcare Limited’s board has issued a Target’s Statement recommending shareholders reject Embark Early Education’s unsolicited takeover offer, citing undervaluation and significant risks. The offer, which includes a scrip or cash option, is seen as opportunistically timed amid Mayfield’s operational turnaround.
Victor Sage
Victor Sage
20 Jan 2026
Telix Pharmaceuticals has met its upgraded FY 2025 revenue guidance with US$804 million, driven by strong growth in its Precision Medicine segment and the successful US launch of Gozellix. The company also advanced multiple clinical trials and announced a strategic collaboration with Varian to combine radiopharmaceuticals with radiation therapy.
Ada Torres
Ada Torres
20 Jan 2026
Nanoveu Limited has raised A$7.5 million through a strategic placement to accelerate the commercial rollout of its cutting-edge EMASS ECS-DoT semiconductor technology, including a rapid 16nm chip tape-out and live drone validation.
Sophie Babbage
Sophie Babbage
20 Jan 2026
Blue Star Helium has achieved its first helium production at the Galactica Project, marking a key milestone as it optimizes plant operations and prepares for commercial ramp-up.
Maxwell Dee
Maxwell Dee
20 Jan 2026